Skip to main content
letter
. 2016 Dec 15;194(12):1552–1555. doi: 10.1164/rccm.201606-1145LE

Table 2.

Omalizumab Is Associated with Reduced Acute Exacerbation Severity

Outcomes Univariate Analysis
Multivariate Analysis
Coef or OR* 95% CI P Value Coef or OR 95% CI P Value
Continuous            
 Exacerbation MPIS −3.32 −4.82 to −1.82 <0.001 −2.83 −4.01 to −1.66 <0.001
 Exacerbation PEF% 16.49 8.56 to 24.42 <0.001 13.72 6.99 to 20.45 <0.001
 Time to albuterol every 2 h −15.85 −24.28 to −7.43 <0.001 −16.59 −24.05 to −9.13 <0.001
 Hospital length of stay −24.01 −37.32 to −10.70 0.001 −24.57 −36.17 to −12.98 <0.001
Dichotomous            
 Hospital admission 0.38 0.16 to 0.88 0.024 0.30 0.11 to 0.83 0.021
 ICU admission 0.31 0.12 to 0.82 0.018 0.24 0.08 to 0.75 0.014
 Supplemental O2 0.26 0.09 to 0.74 0.011 0.24 0.07 to 0.79 0.019
 Noninvasive PPV 0.17 0.04 to 0.74 0.035 0.21 0.04 to 1.01 0.052

Definition of abbreviations: CI = confidence interval; Coef = coefficient; ICU = intensive care unit; MPIS = Modified Pulmonary Index Score; OR = odds ratio; PEF = peak expiratory flow; PPV = positive pressure ventilation.

*

Coefficient for continous variables and OR for dichotomous variables.